The game changing DTP Combination Vaccine evolution to improve VCR.

Speciality: All Speciality


Speaker:

Dr. Suhas Prabhu | Consultant Pediatrician

Dr. Denis Macina | Graduated with an MSc in Immunology from Universite Laval, Quabec

Description:

A warm welcome to all the medical professionals in this interesting session on The game changing DTP Combination Vaccine evolution to improve VCR.
The DTP (Diphtheria, Tetanus, and Pertussis) combination vaccine has been a cornerstone of childhood immunization programs worldwide. Its evolution marks significant advancements in improving vaccine coverage rates (VCR), ensuring broader protection against these serious infectious diseases.
Over the years, the DTP vaccine has undergone several modifications to enhance its efficacy and safety. Initially, whole-cell pertussis vaccines were used, which, although effective, were associated with higher rates of adverse reactions. The development of acellular pertussis vaccines (DTaP) offered a safer alternative with fewer side effects, leading to increased acceptance and higher vaccination rates.
Research is being conducted to develop next-generation vaccines that offer even broader protection with fewer doses. Additionally, efforts to educate communities and address vaccine hesitancy are essential to further improve VCR and sustain the gains achieved in controlling these preventable diseases.
Therefore, get an overall knowledge of the game changing DTP combination vaccine evolution to improve VCR.
 

See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer during young adulthood carries long-term mental toll, study finds

2.

In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.

3.

Surgery after EGFR TKI shows promise in prolonging progression-free survival in metastatic NSCLC

4.

Every cancer is different because of how evolution causes drug resistance and why various cancers require various treatments.

5.

Report: High risk of lung cancer from respirable crystalline silica even below the current occupational exposure limit


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot